Healthcare provider profile · identity verified

Anne M Sutherland, M.D.

Family Practice · TROUTDALE, OR · NPI 1609824051

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	350	80
Atorvastatin Calcium	Atorvastatin Calcium	339	89
Losartan Potassium	Losartan Potassium	262	72
Omeprazole	Omeprazole	249	81
Metoprolol Succinate	Metoprolol Succinate	212	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	184	39
Gabapentin	Gabapentin	181	57
Lisinopril	Lisinopril	177	48
Trazodone Hcl	Trazodone Hcl	175	44
Metformin Hcl Er	Metformin Hcl	170	43
Rosuvastatin Calcium	Rosuvastatin Calcium	164	50
Tramadol Hcl	Tramadol Hcl	158	33
Sertraline Hcl	Sertraline Hcl	155	46
Alendronate Sodium	Alendronate Sodium	151	51
Montelukast Sodium	Montelukast Sodium	143	38
Amlodipine Besylate	Amlodipine Besylate	139	46
Escitalopram Oxalate	Escitalopram Oxalate	137	38
Duloxetine Hcl	Duloxetine Hcl	130	34
Bupropion Xl	Bupropion Hcl	116	34
Furosemide	Furosemide	115	36
Albuterol Sulfate Hfa	Albuterol Sulfate	113	50
Potassium Chloride	Potassium Chloride	106	33
Pantoprazole Sodium	Pantoprazole Sodium	99	27
Eliquis	Apixaban	93	20
Carvedilol	Carvedilol	89	22
Simvastatin	Simvastatin	88	24
Fluoxetine Hcl	Fluoxetine Hcl	84	20
Hydrochlorothiazide	Hydrochlorothiazide	83	26
Pregabalin	Pregabalin	83	26
Ozempic	Semaglutide	81	18
Zolpidem Tartrate	Zolpidem Tartrate	81	22
Lovastatin	Lovastatin	78	22
Alprazolam	Alprazolam	76	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	73	19
Lorazepam	Lorazepam	72	20
Venlafaxine Hcl Er	Venlafaxine Hcl	72	16
Spironolactone	Spironolactone	68	20
Aripiprazole	Aripiprazole	66	18
Atenolol	Atenolol	64	18
Jardiance	Empagliflozin	64	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	24
Tamsulosin Hcl	Tamsulosin Hcl	60	17
Hydroxyzine Hcl	Hydroxyzine Hcl	59	22
Allopurinol	Allopurinol	55	12
Ezetimibe	Ezetimibe	55	16
Fluconazole	Fluconazole	55	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	17
Ondansetron Odt	Ondansetron	52	29
Nystatin	Nystatin	51	28
Myrbetriq	Mirabegron	47	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	suppressed
Metformin Hcl	Metformin Hcl	44	13
Prednisone	Prednisone	44	33
Azelastine Hcl	Azelastine Hcl	42	20
Clopidogrel	Clopidogrel Bisulfate	42	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	12
Fluticasone Propionate	Fluticasone Propionate	40	12
Lamotrigine	Lamotrigine	40	suppressed
Meloxicam	Meloxicam	40	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	13
Estradiol	Estradiol	37	21
Cephalexin	Cephalexin	36	21
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	36	11
Citalopram Hbr	Citalopram Hydrobromide	35	11
Warfarin Sodium	Warfarin Sodium	34	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	20
Propranolol Hcl	Propranolol Hcl	33	13
Trulicity	Dulaglutide	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	23
Baclofen	Baclofen	29	14
Metoprolol Tartrate	Metoprolol Tartrate	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	22
Oxycodone Hcl	Oxycodone Hcl	28	14
Betamethasone Dipropionate	Betamethasone Dipropionate	27	21
Clonazepam	Clonazepam	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	21
Glipizide Er	Glipizide	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Glipizide	Glipizide	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Varenicline Tartrate	Varenicline Tartrate	26	suppressed
Mupirocin	Mupirocin	25	20
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Topiramate	Topiramate	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	18
Lidocaine	Lidocaine	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Azithromycin	Azithromycin	18	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Nitroglycerin	Nitroglycerin	17	13
Valsartan	Valsartan	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Novolin R	Insulin Regular, Human	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Famotidine	Famotidine	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Digoxin	Digoxin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error